OBJECTIVES: This study sought to identify the frequency, pattern, and prognostic significance of left ventricular (LV) late gadolinium enhancement (LGE) in patients with atrial fibrillation (AF). BACKGROUND: There are limited data on the presence, pattern, and prognostic significance of LV myocardial fibrosis in patients with AF. LGE during cardiac magnetic resonance imaging is a marker for myocardial fibrosis. METHODS: A group of 664 consecutive patients without known prior myocardial infarction who were referred for radiofrequency ablation of AF were studied. Cardiac magnetic resonance imaging was requested to assess pulmonary venous anatomy. RESULTS: Overall, 73% were men, with a mean age of 56 years and a mean LV ejection fraction of 56 ± 10%. LV LGE was found in 88 patients (13%). The endpoint was all-cause mortality, and in this cohort, 68 deaths were observed over a median follow-up period of 42 months. On univariate analysis, age (hazard ratio [HR]: 1.05; 95% confidence interval [CI]: 1.03 to 1.08; chi-square likelihood ratio [LRχ(2)]: 15.2; p = 0.0001), diabetes (HR: 2.39; 95% CI: 1.41 to 4.09; LRχ(2): 10.3; p = 0.001), a history of heart failure (HR: 1.78; 95% CI: 1.09 to 2.91; LRχ(2): 5.37; p = 0.02), left atrial dimension (HR: 1.04; 95% CI: 1.01 to 1.08; LRχ(2): 6.47; p = 0.01), presence of LGE (HR: 5.08; 95% CI: 3.08 to 8.36; LRχ(2): 28.8; p < 0.0001), and LGE extent (HR: 1.15; 95% CI: 1.10 to 1.21; LRχ(2): 35.6; p < 0.0001) provided the strongest associations with mortality. The mortality rate was 8.1% per patient-year in patients with LGE compared with 2.3% patients without LGE. In the best overall multivariate model for mortality, age and the extent of LGE were independent predictors of mortality. Indeed, each 1% increase in the extent of LGE was associated with a 15% increased risk for death. CONCLUSIONS: In patients with AF, LV LGE is a frequent finding and is a powerful predictor of mortality.
OBJECTIVES: This study sought to identify the frequency, pattern, and prognostic significance of left ventricular (LV) late gadolinium enhancement (LGE) in patients with atrial fibrillation (AF). BACKGROUND: There are limited data on the presence, pattern, and prognostic significance of LV myocardial fibrosis in patients with AF. LGE during cardiac magnetic resonance imaging is a marker for myocardial fibrosis. METHODS: A group of 664 consecutive patients without known prior myocardial infarction who were referred for radiofrequency ablation of AF were studied. Cardiac magnetic resonance imaging was requested to assess pulmonary venous anatomy. RESULTS: Overall, 73% were men, with a mean age of 56 years and a mean LV ejection fraction of 56 ± 10%. LV LGE was found in 88 patients (13%). The endpoint was all-cause mortality, and in this cohort, 68 deaths were observed over a median follow-up period of 42 months. On univariate analysis, age (hazard ratio [HR]: 1.05; 95% confidence interval [CI]: 1.03 to 1.08; chi-square likelihood ratio [LRχ(2)]: 15.2; p = 0.0001), diabetes (HR: 2.39; 95% CI: 1.41 to 4.09; LRχ(2): 10.3; p = 0.001), a history of heart failure (HR: 1.78; 95% CI: 1.09 to 2.91; LRχ(2): 5.37; p = 0.02), left atrial dimension (HR: 1.04; 95% CI: 1.01 to 1.08; LRχ(2): 6.47; p = 0.01), presence of LGE (HR: 5.08; 95% CI: 3.08 to 8.36; LRχ(2): 28.8; p < 0.0001), and LGE extent (HR: 1.15; 95% CI: 1.10 to 1.21; LRχ(2): 35.6; p < 0.0001) provided the strongest associations with mortality. The mortality rate was 8.1% per patient-year in patients with LGE compared with 2.3% patients without LGE. In the best overall multivariate model for mortality, age and the extent of LGE were independent predictors of mortality. Indeed, each 1% increase in the extent of LGE was associated with a 15% increased risk for death. CONCLUSIONS: In patients with AF, LV LGE is a frequent finding and is a powerful predictor of mortality.
Authors: D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley Journal: N Engl J Med Date: 2002-12-05 Impact factor: 91.245
Authors: Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns Journal: N Engl J Med Date: 2002-12-05 Impact factor: 91.245
Authors: Mark A Wood; Michael Wittkamp; Daniel Henry; Robert Martin; J V Nixon; Richard K Shepard; Kenneth A Ellenbogen Journal: Am J Cardiol Date: 2004-01-01 Impact factor: 2.778
Authors: Stefan Grün; Julia Schumm; Simon Greulich; Anja Wagner; Steffen Schneider; Oliver Bruder; Eva-Maria Kispert; Stephan Hill; Peter Ong; Karin Klingel; Reinhardt Kandolf; Udo Sechtem; Heiko Mahrholdt Journal: J Am Coll Cardiol Date: 2012-02-22 Impact factor: 24.094
Authors: Ritsushi Kato; Lars Lickfett; Glenn Meininger; Timm Dickfeld; Richard Wu; George Juang; Piamsook Angkeow; Jennifer LaCorte; David Bluemke; Ronald Berger; Henry R Halperin; Hugh Calkins Journal: Circulation Date: 2003-04-07 Impact factor: 29.690
Authors: W S Lin; V S Prakash; C T Tai; M H Hsieh; C F Tsai; W C Yu; Y K Lin; Y A Ding; M S Chang; S A Chen Journal: Circulation Date: 2000-03-21 Impact factor: 29.690
Authors: Benoit Ghaye; David Szapiro; Jean-Nicolas Dacher; Luz-Maria Rodriguez; Carl Timmermans; David Devillers; Robert F Dondelinger Journal: Radiographics Date: 2003-10 Impact factor: 5.333
Authors: Thomas J Wang; Joseph M Massaro; Daniel Levy; Ramachandran S Vasan; Philip A Wolf; Ralph B D'Agostino; Martin G Larson; William B Kannel; Emelia J Benjamin Journal: JAMA Date: 2003-08-27 Impact factor: 56.272
Authors: Nassir F Marrouche; David O Martin; Oussama Wazni; A Marc Gillinov; Allan Klein; Mandeep Bhargava; Eduardo Saad; Dianna Bash; Hirotsugu Yamada; Wael Jaber; Robert Schweikert; Patrick Tchou; Ahmad Abdul-Karim; Walid Saliba; Andrea Natale Journal: Circulation Date: 2003-05-19 Impact factor: 29.690
Authors: Tomas G Neilan; Jessie P Bakker; Bhavneesh Sharma; Robert L Owens; Hoshang Farhad; Ravi V Shah; Siddique A Abbasi; Puja Kohli; Joel Wilson; Anthony DeMaria; Michael Jerosch-Herold; Raymond Y Kwong; Atul Malhotra Journal: Can J Cardiol Date: 2014-08-19 Impact factor: 5.223
Authors: Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan Journal: J Am Coll Cardiol Date: 2018-03-19 Impact factor: 24.094
Authors: Tomas G Neilan; Hoshang Farhad; Thomas Mayrhofer; Ravi V Shah; John A Dodson; Siddique A Abbasi; Stephan B Danik; Daniel J Verdini; Michifumi Tokuda; Usha B Tedrow; Michael Jerosch-Herold; Udo Hoffmann; Brian B Ghoshhajra; William G Stevenson; Raymond Y Kwong Journal: JACC Cardiovasc Imaging Date: 2015-03-18